Two-Component Ferritin Nanoparticles for Multimerization of Diverse Trimeric Antigens

ACS Infectious Diseases

Volumn 4, Issue 5, 2018, Pages 788-796

  Georgiev, Ivelin S ^a   Joyce, Michael Gordon ^a   Chen, Rita E ^a   Leung, Kwanyee ^a   McKee, Krisha ^a   Druz, Aliaksandr ^a   Van Galen, Joseph G ^a   Kanekiyo, Masaru ^a   Tsybovsky, Yaroslav ^b   Yang, Eun Sung ^a   Yang, Yongping ^a   Acharya, Priyamvada ^a   Pancera, Marie ^a   Thomas, Paul V ^a   Wanninger, Timothy ^a   Yassine, Hadi M ^a   Baxa, Ulrich ^b   Doria Rose, Nicole A ^a   Cheng, Cheng ^a   Graham, Barney S ^a   Mascola, John R ^a   Kwong, Peter D ^a   more..

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

Author keywords

antibody; HIV 1; immunogenicity; influenza; vaccine

Indexed keywords

FERRITIN; GLYCOPROTEIN GP 140; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; INFLUENZA VIRUS HEMAGGLUTININ; NANOPARTICLE; NEUTRALIZING ANTIBODY; ANTIGEN; EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; RECOMBINANT PROTEIN; VIRUS ENVELOPE PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ARTICLE; CELL LYSATE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HARTLEY GUINEA PIG; HUMAN IMMUNODEFICIENCY VIRUS 1; NEGATIVE STAINING; NONHUMAN; PRIORITY JOURNAL; PROTEIN MULTIMERIZATION; REPORTER GENE; TRICHOPLUSIA NI; VIRUS ENVELOPE; VIRUS NEUTRALIZATION; CHEMISTRY; HUMAN; IMMUNOLOGY; MOLECULAR MODEL; PROTEIN CONFORMATION; ULTRASTRUCTURE;

ANTIGENS; EPITOPES; FERRITINS; GENE PRODUCTS, ENV; HIV ANTIBODIES; HIV-1; HUMANS; MODELS, MOLECULAR; NANOPARTICLES; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; RECOMBINANT PROTEINS;

EID: 85046836454     PISSN: None     EISSN: 23738227     Source Type: Journal    
DOI: 10.1021/acsinfecdis.7b00192     Document Type: Article

References (36)

1. Bachmann, M. F. and Zinkernagel, R. M. (1997) Neutralizing antiviral B cell responses. Annu. Rev. Immunol. 15 (1), 235-270, 10.1146/annurev.immunol.15.1.235
2. Hinton, H. J., Jegerlehner, A., and Bachmann, M. F. (2008) Pattern recognition by B cells: the role of antigen repetitiveness versus Toll-like receptors. Curr. Top. Microbiol. Immunol. 319, 1-15, 10.1007/978-3-540-73900-5-1
3. Bachmann, M. F. and Jennings, G. T. (2010) Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat. Rev. Immunol. 10 (11), 787-796, 10.1038/nri2868
4. Bachmann, M. F., Rohrer, U. H., Kundig, T. M., Burki, K., Hengartner, H., and Zinkernagel, R. M. (1993) The influence of antigen organization on B cell responsiveness. Science 262 (5138), 1448-51, 10.1126/science.8248784
5. Dintzis, H. M., Dintzis, R. Z., and Vogelstein, B. (1976) Molecular determinants of immunogenicity: the immunon model of immune response. Proc. Natl. Acad. Sci. U. S. A. 73 (10), 3671-5, 10.1073/pnas.73.10.3671
6. Zhao, L., Seth, A., Wibowo, N., Zhao, C.-X., Mitter, N., Yu, C., and Middelberg, A. P. J. (2014) Nanoparticle vaccines. Vaccine 32 (3), 327-337, 10.1016/j.vaccine.2013.11.069
7. Kanekiyo, M., Wei, C. J., Yassine, H. M., McTamney, P. M., Boyington, J. C., Whittle, J. R., Rao, S. S., Kong, W. P., Wang, L., and Nabel, G. J. (2013) Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature 499 (7456), 102-6, 10.1038/nature12202
8. Sliepen, K., Ozorowski, G., Burger, J. A., van Montfort, T., Stunnenberg, M., LaBranche, C., Montefiori, D. C., Moore, J. P., Ward, A. B., and Sanders, R. W. (2015) Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity. Retrovirology 12 (1), 82, 10.1186/s12977-015-0210-4
9. Kanekiyo, M., Bu, W., Joyce, M. G., Meng, G., Whittle, J. R. R., Baxa, U., Yamamoto, T., Todd, J. P., Rao, S. S., Koup, R. A., Rossmann, M. G., Mascola, J. R., Graham, B. S., Cohen, J. I., Nabel, G. J. et al. (2015) Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site. Cell 162 (5), 1090-1100, 10.1016/j.cell.2015.07.043
10. Jardine, J., Julien, J. P., Menis, S., Ota, T., Kalyuzhniy, O., McGuire, A., Sok, D., Huang, P. S., MacPherson, S., Jones, M., Nieusma, T., Mathison, J., Baker, D., Ward, A. B., Burton, D. R., Stamatatos, L., Nemazee, D., Wilson, I. A., and Schief, W. R. (2013) Rational HIV immunogen design to target specific germline B cell receptors. Science 340 (6133), 711-6, 10.1126/science.1234150
11. Bale, J. B., Gonen, S., Liu, Y., Sheffler, W., Ellis, D., Thomas, C., Cascio, D., Yeates, T. O., Gonen, T., King, N. P., and Baker, D. (2016) Accurate design of megadalton-scale two-component icosahedral protein complexes. Science 353 (6297), 389-94, 10.1126/science.aaf8818
12. King, N. P., Bale, J. B., Sheffler, W., McNamara, D. E., Gonen, S., Gonen, T., Yeates, T. O., and Baker, D. (2014) Accurate design of co-assembling multi-component protein nanomaterials. Nature 510 (7503), 103-8, 10.1038/nature13404
13. Phippen, S. W., Stevens, C. A., Vance, T. D., King, N. P., Baker, D., and Davies, P. L. (2016) Multivalent Display of Antifreeze Proteins by Fusion to Self-Assembling Protein Cages Enhances Ice-Binding Activities. Biochemistry 55 (49), 6811-6820, 10.1021/acs.biochem.6b00864
14. Sanders, R. W., Derking, R., Cupo, A., Julien, J. P., Yasmeen, A., de Val, N., Kim, H. J., Blattner, C., de la Pena, A. T., Korzun, J., Golabek, M., de Los Reyes, K., Ketas, T. J., van Gils, M. J., King, C. R., Wilson, I. A., Ward, A. B., Klasse, P. J., and Moore, J. P. (2013) A next-generation cleaved, soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies. PLoS Pathog. 9 (9), e1003618, 10.1371/journal.ppat.1003618
15. Hamburger, A. E., West, A. P., Jr., Hamburger, Z. A., Hamburger, P., and Bjorkman, P. J. (2005) Crystal structure of a secreted insect ferritin reveals a symmetrical arrangement of heavy and light chains. J. Mol. Biol. 349 (3), 558-569, 10.1016/j.jmb.2005.03.074
16. Shang, H., Han, X., Shi, X., Zuo, T., Goldin, M., Chen, D., Han, B., Sun, W., Wu, H., Wang, X., and Zhang, L. (2011) Genetic and neutralization sensitivity of diverse HIV-1 env clones from chronically infected patients in China. J. Biol. Chem. 286 (16), 14531-41, 10.1074/jbc.M111.224527
17. Joyce, M. G., Georgiev, I. S., Yang, Y., Druz, A., Geng, H., Chuang, G. Y., Kwon, Y. D., Pancera, M., Rawi, R., Sastry, M., Stewart-Jones, G. B. E., Zheng, A., Zhou, T., Choe, M., Van Galen, J. G., Chen, R. E., Lees, C. R., Narpala, S., Chambers, M., Tsybovsky, Y., Baxa, U., McDermott, A. B., Mascola, J. R., and Kwong, P. D. (2017) Soluble Prefusion Closed DS-SOSIP.664-Env Trimers of Diverse HIV-1 Strains. Cell Rep. 21 (10), 2992-3002, 10.1016/j.celrep.2017.11.016
18. Do Kwon, Y., Pancera, M., Acharya, P., Georgiev, I. S., Crooks, E. T., Gorman, J., Joyce, M. G., Guttman, M., Ma, X., Narpala, S., Soto, C., Terry, D. S., Yang, Y., Zhou, T., Ahlsen, G., Bailer, R. T., Chambers, M., Chuang, G. Y., Doria-Rose, N. A., Druz, A., Hallen, M. A., Harned, A., Kirys, T., Louder, M. K., O'Dell, S., Ofek, G., Osawa, K., Prabhakaran, M., Sastry, M., Stewart-Jones, G. B., Stuckey, J., Thomas, P. V., Tittley, T., Williams, C., Zhang, B., Zhao, H., Zhou, Z., Donald, B. R., Lee, L. K., Zolla-Pazner, S., Baxa, U., Schon, A., Freire, E., Shapiro, L., Lee, K. K., Arthos, J., Munro, J. B., Blanchard, S. C., Mothes, W., Binley, J. M., McDermott, A. B., Mascola, J. R., and Kwong, P. D. (2015) Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env. Nat. Struct. Mol. Biol. 22 (7), 522-31, 10.1038/nsmb.3051
19. Derdeyn, C. A., Decker, J. M., Bibollet-Ruche, F., Mokili, J. L., Muldoon, M., Denham, S. A., Heil, M. L., Kasolo, F., Musonda, R., Hahn, B. H., Shaw, G. M., Korber, B. T., Allen, S., and Hunter, E. (2004) Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 303 (5666), 2019-2022, 10.1126/science.1093137
20. Doria-Rose, N. A., Schramm, C. A., Gorman, J., Moore, P. L., Bhiman, J. N., DeKosky, B. J., Ernandes, M. J., Georgiev, I. S., Kim, H. J., Pancera, M., Staupe, R. P., Altae-Tran, H. R., Bailer, R. T., Crooks, E. T., Cupo, A., Druz, A., Garrett, N. J., Hoi, K. H., Kong, R., Louder, M. K., Longo, N. S., McKee, K., Nonyane, M., O'Dell, S., Roark, R. S., Rudicell, R. S., Schmidt, S. D., Sheward, D. J., Soto, C., Wibmer, C. K., Yang, Y., Zhang, Z., Mullikin, J. C., Binley, J. M., Sanders, R. W., Wilson, I. A., Moore, J. P., Ward, A. B., Georgiou, G., Williamson, C., Abdool Karim, S. S., Morris, L., Kwong, P. D., Shapiro, L., Mascola, J. R., Becker, J., Benjamin, B., Blakesley, R., Bouffard, G., Brooks, S., Coleman, H., Dekhtyar, M., Gregory, M., Guan, X., Gupta, J., Han, J., Hargrove, A., Ho, S. L., Johnson, T., Legaspi, R., Lovett, S., Maduro, Q., Masiello, C., Maskeri, B., McDowell, J., Montemayor, C., Mullikin, J., Park, M., Riebow, N., Schandler, K., Schmidt, B., Sison, C., Stantripop, M., Thomas, J., Thomas, P., Vemulapalli, M., and Young, A. (2014) Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature 509 (7498), 55-62, 10.1038/nature13036
21. McLellan, J. S., Pancera, M., Carrico, C., Gorman, J., Julien, J. P., Khayat, R., Louder, R., Pejchal, R., Sastry, M., Dai, K., O'Dell, S., Patel, N., Shahzad-ul-Hussan, S., Yang, Y., Zhang, B., Zhou, T., Zhu, J., Boyington, J. C., Chuang, G. Y., Diwanji, D., Georgiev, I., Kwon, Y. D., Lee, D., Louder, M. K., Moquin, S., Schmidt, S. D., Yang, Z. Y., Bonsignori, M., Crump, J. A., Kapiga, S. H., Sam, N. E., Haynes, B. F., Burton, D. R., Koff, W. C., Walker, L. M., Phogat, S., Wyatt, R., Orwenyo, J., Wang, L. X., Arthos, J., Bewley, C. A., Mascola, J. R., Nabel, G. J., Schief, W. R., Ward, A. B., Wilson, I. A., and Kwong, P. D. (2011) Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature 480 (7377), 336-343, 10.1038/nature10696
22. Julien, J. P., Cupo, A., Sok, D., Stanfield, R. L., Lyumkis, D., Deller, M. C., Klasse, P. J., Burton, D. R., Sanders, R. W., Moore, J. P., Ward, A. B., and Wilson, I. A. (2013) Crystal structure of a soluble cleaved HIV-1 envelope trimer. Science 342 (6165), 1477-83, 10.1126/science.1245625
23. Gorny, M. K., Conley, A. J., Karwowska, S., Buchbinder, A., Xu, J. Y., Emini, E. A., Koenig, S., and Zolla-Pazner, S. (1992) Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody. J. Virol. 66 (12), 7538-7542
24. Wu, X., Yang, Z. Y., Li, Y., Hogerkorp, C. M., Schief, W. R., Seaman, M. S., Zhou, T., Schmidt, S. D., Wu, L., Xu, L., Longo, N. S., McKee, K., O'Dell, S., Louder, M. K., Wycuff, D. L., Feng, Y., Nason, M., Doria-Rose, N., Connors, M., Kwong, P. D., Roederer, M., Wyatt, R. T., Nabel, G. J., and Mascola, J. R. (2010) Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 329 (5993), 856-61, 10.1126/science.1187659
25. Roben, P., Moore, J. P., Thali, M., Sodroski, J., Barbas, C. F., 3rd, and Burton, D. R. (1994) Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. J. Virol. 68 (8), 4821-4828
26. Walker, L. M., Huber, M., Doores, K. J., Falkowska, E., Pejchal, R., Julien, J. P., Wang, S. K., Ramos, A., Chan-Hui, P. Y., Moyle, M., Mitcham, J. L., Hammond, P. W., Olsen, O. A., Phung, P., Fling, S., Wong, C. H., Phogat, S., Wrin, T., Simek, M. D., Koff, W. C., Wilson, I. A., Burton, D. R., and Poignard, P. (2011) Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 477 (7365), 466-470, 10.1038/nature10373
27. Huang, J., Kang, B. H., Pancera, M., Lee, J. H., Tong, T., Feng, Y., Imamichi, H., Georgiev, I. S., Chuang, G. Y., Druz, A., Doria-Rose, N. A., Laub, L., Sliepen, K., van Gils, M. J., de la Pena, A. T., Derking, R., Klasse, P. J., Migueles, S. A., Bailer, R. T., Alam, M., Pugach, P., Haynes, B. F., Wyatt, R. T., Sanders, R. W., Binley, J. M., Ward, A. B., Mascola, J. R., Kwong, P. D., and Connors, M. (2014) Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface. Nature 515 (7525), 138-42, 10.1038/nature13601
28. Blattner, C., Lee, J. H., Sliepen, K., Derking, R., Falkowska, E., de la Pena, A. T., Cupo, A., Julien, J. P., van Gils, M., Lee, P. S., Peng, W., Paulson, J. C., Poignard, P., Burton, D. R., Moore, J. P., Sanders, R. W., Wilson, I. A., and Ward, A. B. (2014) Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers. Immunity 40 (5), 669-80, 10.1016/j.immuni.2014.04.008
29. Lee, P. S., Ohshima, N., Stanfield, R. L., Yu, W., Iba, Y., Okuno, Y., Kurosawa, Y., and Wilson, I. A. (2014) Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus. Nat. Commun. 5, 3614, 10.1038/ncomms4614
30. Chuang, G. Y., Acharya, P., Schmidt, S. D., Yang, Y., Louder, M. K., Zhou, T., Kwon, Y. D., Pancera, M., Bailer, R. T., Doria-Rose, N. A., Nussenzweig, M. C., Mascola, J. R., Kwong, P. D., and Georgiev, I. S. (2013) Residue-level prediction of HIV-1 antibody epitopes based on neutralization of diverse viral strains. Journal of virology 87 (18), 10047-58, 10.1128/JVI.00984-13
31. Zhou, T., Doria-Rose, N. A., Cheng, C., Stewart-Jones, G. B. E., Chuang, G. Y., Chambers, M., Druz, A., Geng, H., McKee, K., Kwon, Y. D., O'Dell, S., Sastry, M., Schmidt, S. D., Xu, K., Chen, L., Chen, R. E., Louder, M. K., Pancera, M., Wanninger, T. G., Zhang, B., Zheng, A., Farney, S. K., Foulds, K. E., Georgiev, I. S., Joyce, M. G., Lemmin, T., Narpala, S., Rawi, R., Soto, C., Todd, J. P., Shen, C. H., Tsybovsky, Y., Yang, Y., Zhao, P., Haynes, B. F., Stamatatos, L., Tiemeyer, M., Wells, L., Scorpio, D. G., Shapiro, L., McDermott, A. B., Mascola, J. R., and Kwong, P. D. (2017) Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation. Cell Rep. 19 (4), 719-732, 10.1016/j.celrep.2017.04.013
32. Montefiori, D. C. (2009) Measuring HIV neutralization in a luciferase reporter gene assay. Methods Mol. Biol. 485, 395-405, 10.1007/978-1-59745-170-3-26
33. Shu, Y., Winfrey, S., Yang, Z. Y., Xu, L., Rao, S. S., Srivastava, I., Barnett, S. W., Nabel, G. J., and Mascola, J. R. (2007) Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs. Vaccine 25 (8), 1398-408, 10.1016/j.vaccine.2006.10.046
34. Seaman, M. S., Janes, H., Hawkins, N., Grandpre, L. E., Devoy, C., Giri, A., Coffey, R. T., Harris, L., Wood, B., Daniels, M. G., Bhattacharya, T., Lapedes, A., Polonis, V. R., McCutchan, F. E., Gilbert, P. B., Self, S. G., Korber, B. T., Montefiori, D. C., and Mascola, J. R. (2010) Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. Journal of virology 84 (3), 1439-52, 10.1128/JVI.02108-09
35. Bottcher, E., Matrosovich, T., Beyerle, M., Klenk, H. D., Garten, W., and Matrosovich, M. (2006) Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. Journal of virology 80 (19), 9896-8, 10.1128/JVI.01118-06
36. Talaat, K. R., Karron, R. A., Callahan, K. A., Luke, C. J., DiLorenzo, S. C., Chen, G. L., Lamirande, E. W., Jin, H., Coelingh, K. L., Murphy, B. R., Kemble, G., and Subbarao, K. (2009) A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. Vaccine 27 (28), 3744-53, 10.1016/j.vaccine.2009.03.082